Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3086% above fair value
$114.63−1.25 (-1.07%)
Close on Nov 20, 2026Market cap $23.36BP/E 61.0Yield –
Incyte net income
Net income is the profit left for shareholders after every expense, interest and tax.
Incyte's net income for the twelve months ending Sep 30, 2026 was $403.41M, down 66.1% year over year. For fiscal 2025 it was $1.29B, up 3845.0% from the year before. The highest annual figure on record is $1.29B in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29B | +3845.0% |
| FY2024 | Dec 31, 2024 | $32.62M | -94.5% |
| FY2023 | Dec 31, 2023 | $597.60M | +75.4% |
| FY2022 | Dec 31, 2022 | $340.66M | -64.1% |
| FY2021 | Dec 31, 2021 | $948.58M | – |
| FY2020 | Dec 31, 2020 | -$295.70M | -166.2% |
| FY2019 | Dec 31, 2019 | $446.91M | +308.2% |
| FY2018 | Dec 31, 2018 | $109.49M | – |
| FY2017 | Dec 31, 2017 | -$313.14M | -400.5% |
| FY2016 | Dec 31, 2016 | $104.22M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$784.80M | -285.0% |
| Q2 FY2026 | Jun 30, 2026 | $585.61M | +44.6% |
| Q1 FY2026 | Mar 31, 2026 | $303.33M | +91.7% |
| Q4 FY2025 | Dec 31, 2025 | $299.28M | +48.7% |
| Q3 FY2025 | Sep 30, 2025 | $424.17M | +298.4% |
| Q2 FY2025 | Jun 30, 2025 | $405.00M | – |
| Q1 FY2025 | Mar 31, 2025 | $158.20M | -6.7% |
| Q4 FY2024 | Dec 31, 2024 | $201.21M | +0.1% |
| Q3 FY2024 | Sep 30, 2024 | $106.46M | -37.8% |
| Q2 FY2024 | Jun 30, 2024 | -$444.60M | -318.4% |
| Q1 FY2024 | Mar 31, 2024 | $169.55M | +681.2% |
| Q4 FY2023 | Dec 31, 2023 | $201.08M | +606.5% |
| Q3 FY2023 | Sep 30, 2023 | $171.27M | +51.9% |
| Q2 FY2023 | Jun 30, 2023 | $203.55M | +26.1% |
| Q1 FY2023 | Mar 31, 2023 | $21.70M | -42.9% |
| Q4 FY2022 | Dec 31, 2022 | $28.46M | -95.0% |
| Q3 FY2022 | Sep 30, 2022 | $112.78M | -37.9% |
| Q2 FY2022 | Jun 30, 2022 | $161.43M | +8.0% |
| Q1 FY2022 | Mar 31, 2022 | $37.99M | -29.0% |
| Q4 FY2021 | Dec 31, 2021 | $563.85M | +276.3% |
| Q3 FY2021 | Sep 30, 2021 | $181.74M | – |
| Q2 FY2021 | Jun 30, 2021 | $149.46M | -48.5% |
| Q1 FY2021 | Mar 31, 2021 | $53.54M | – |
| Q4 FY2020 | Dec 31, 2020 | $149.85M | +35.0% |
| Q3 FY2020 | Sep 30, 2020 | -$15.20M | -111.9% |
| Q2 FY2020 | Jun 30, 2020 | $290.30M | +175.6% |
| Q1 FY2020 | Mar 31, 2020 | -$720.64M | -804.4% |
| Q4 FY2019 | Dec 31, 2019 | $111.01M | +60.7% |
| Q3 FY2019 | Sep 30, 2019 | $128.27M | +339.6% |
| Q2 FY2019 | Jun 30, 2019 | $105.32M | +101.0% |
| Q1 FY2019 | Mar 31, 2019 | $102.31M | – |
| Q4 FY2018 | Dec 31, 2018 | $69.06M | – |
| Q3 FY2018 | Sep 30, 2018 | $29.18M | -19.1% |
| Q2 FY2018 | Jun 30, 2018 | $52.39M | – |
| Q1 FY2018 | Mar 31, 2018 | -$41.14M | – |
| Q4 FY2017 | Dec 31, 2017 | -$149.63M | – |
| Q3 FY2017 | Sep 30, 2017 | $36.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.48M | – |
| Q1 FY2017 | Mar 31, 2017 | -$187.08M | – |
See a number that looks wrong?